Search results for "Lipids"

showing 10 items of 2228 documents

Inhibition of giant cell formation by compound 48/80 after infection with herpesvirus hominis

1974

Choline kinase has been found to be a soluble enzyme with a molecular weight of 105,000 in the cytoplasm of primary rabbit kidney cells. It has been purified 150-fold. It was investigated whether the inhibiting effect of Cpd 48/80 on virus-induced giant cell formation is due to interference with this enzyme. Cpd 48/80-dimer was shown to inhibit the choline kinase activityin vitro without a concomitant inhibition of giant cell formation. Likewise, another competitive inhibitor of choline kinase, purinyl-6-histamine, does not prevent giant cell formation. This finding suggests that there is no correlation between choline kinase activity and giant cell formation.

Time FactorsCholine kinaseeducationGalactosamineOleic AcidsBiologyKidneyTritiumCholinechemistry.chemical_compoundCytopathogenic Effect ViralBiosynthesisVirologyAnimalsSimplexvirusp-Methoxy-N-methylphenethylamineCarbon RadioisotopesCells Culturedchemistry.chemical_classificationGlucosamineBinding SitesPhosphotransferasesGeneral MedicineCompound 48/80LipidsVirologyMolecular biologyIn vitroEnzymechemistryEthanolaminesCytoplasmGiant cellDepression ChemicalPhosphatidylcholinesTritiumChromatography Thin LayerRabbitsArchiv f�r die gesamte Virusforschung
researchProduct

Worldwide burden of LDL cholesterol: Implications in cardiovascular disease

2020

Abstract Background and aim an increased value of low-density lipoprotein cholesterol (LDL-C) is now universally considered a major cardiovascular disease (CVD) risk factor. LDL-C is included in the vast majority of worldwide cardiovascular risk prediction algorithms, as well as in the guidelines for cardiovascular risk prevention. We aimed to provide an overview of the worldwide adverse healthcare impact of low-density lipoprotein cholesterol (LDL-C). Methods and results Data on the epidemiologic burden of LDL-C >1.3 mmol/L were retrieved from Global Health Data Exchange (GHDx) registry. The current burden is 94.92 million disability-adjusted life years (DALYs), with an exponential increas…

Time FactorsDatabases FactualHealth StatusEndocrinology Diabetes and MetabolismMedicine (miscellaneous)030209 endocrinology & metabolismDisease030204 cardiovascular system & hematologyGlobal HealthRisk Assessment03 medical and health scienceschemistry.chemical_compound0302 clinical medicineRisk FactorsEnvironmental healthHealth careGlobal healthHumansMedicineRegistriesRisk factorEpidemicsAtherosclerosis; Cardiovascular disease; Cholesterol; Low-density lipoproteinsDyslipidemiasLdl cholesterolNutrition and Dieteticsbusiness.industryCholesterolCholesterol LDLAtherosclerosisCardiovascular diseaseUp-RegulationPrediction algorithmsCholesterolchemistryCardiovascular DiseasesLow-density lipoproteinslipids (amino acids peptides and proteins)Risk preventionQuality-Adjusted Life YearsCardiology and Cardiovascular MedicinebusinessBiomarkersNutrition, Metabolism and Cardiovascular Diseases
researchProduct

Function of DcuS from Escherichia coli as a Fumarate-stimulated Histidine Protein Kinase in Vitro

2002

The two-component regulatory system DcuSR of Escherichia coli controls the expression of genes of C(4)-dicarboxylate metabolism in response to extracellular C(4)- dicarboxylates such as fumarate or succinate. DcuS is a membrane-integral sensor kinase, and the sensory and kinase domains are located on opposite sides of the cytoplasmic membrane. The intact DcuS protein (His(6)-DcuS) was overproduced and isolated in detergent containing buffer. His(6)-DcuS was reconstituted into liposomes made from E. coli phospholipids. Reconstituted His(6)-DcuS catalyzed, in contrast to the detergent-solubilized sensor, autophosphorylation by [gamma-(33)P]ATP with an approximate K(D) of 0.16 mm for ATP. Up t…

Time FactorsHistidine KinaseProteolipidsDetergentsBiologymedicine.disease_causeModels BiologicalBiochemistryAdenosine TriphosphateFumaratesEscherichia colimedicinePhosphorylationPromoter Regions GeneticProtein kinase AMolecular BiologyEscherichia coliDose-Response Relationship DrugKinaseEscherichia coli ProteinsCell MembraneAutophosphorylationDNACell BiologyTransmembrane proteinDNA-Binding ProteinsKineticsResponse regulatorBiochemistryLiposomesPhosphorylationSignal transductionProtein KinasesProtein BindingSignal TransductionTranscription FactorsJournal of Biological Chemistry
researchProduct

The effect of long-chain bases on polysialic acid-mediated membrane interactions

2011

AbstractNegatively-charged polysialic acid (polySia) chains are usually membrane-bound and are often expressed on the surface of neuroinvasive bacterial cells, neural cells, and tumor cells. PolySia can mediate both repulsive and attractive cis interactions between membrane components, and trans interactions between membranes. Positively-charged long-chain bases are widely present in cells, are often localized in membranes and can function as bioactive lipids. Here we use Langmuir monolayer technique, fluorescence spectroscopy and electron microscopy of lipid vesicles to study the role of a simple long-chain base, octadecylamine (ODA), in both cis and trans interactions mediated by polySia …

Time FactorsLipid BilayersBiophysicsPolysialic acidPhospholipid monolayerBiochemistryFluorescenceMembrane LipidsMicroscopy Electron TransmissionMonolayerPressureElectron microscopyMoleculeAminesLipid bilayerLiposomeModels StatisticalChemistryPolysialic acidVesicleCell MembraneOctadecylamineCell BiologyHydrogen-Ion ConcentrationHydrocarbonsLiposomeMicroscopy ElectronSpectrometry FluorescenceMembraneBiochemistryLiposomesPhosphatidylcholinesSialic AcidsBiophysicsThermodynamicsCis–trans isomerismBiochimica et Biophysica Acta (BBA) - Biomembranes
researchProduct

Cholesterol Modulates the Interaction of β-Amyloid Peptide with Lipid Bilayers

2009

The interaction of an amphiphilic, 40-amino acid beta-amyloid (Abeta) peptide with liposomal membranes as a function of sterol mole fraction (X(sterol)) was studied based on the fluorescence anisotropy of a site-specific membrane sterol probe, dehydroergosterol (DHE), and fluorescence resonance energy transfer (FRET) from the native Tyr-10 residue of Abeta to DHE. Without Abeta, peaks or kinks in the DHE anisotropy versus X(sterol) plot were detected at X(sterol) approximately 0.25, 0.33, and 0.53. Monomeric Abeta preserved these peaks/kinks, but oligomeric Abeta suppressed them and created a new DHE anisotropy peak at X(sterol) approximately 0.38. The above critical X(sterol) values coinci…

Time FactorsLipid BilayersMolecular Sequence DataBiophysicsPeptideFluorescence Polarization7. Clean energy03 medical and health scienceschemistry.chemical_compound0302 clinical medicineAlzheimer DiseaseErgosterolFluorescence Resonance Energy TransferAmino Acid SequenceLipid bilayer030304 developmental biologychemistry.chemical_classification0303 health sciencesLiposomeAmyloid beta-PeptidesChemistryCholesterolSterolPeptide FragmentsCrystallographyFörster resonance energy transferMembraneCholesterolCell BiophysicsTyrosinelipids (amino acids peptides and proteins)030217 neurology & neurosurgeryFluorescence anisotropyProtein BindingBiophysical Journal
researchProduct

Paclitaxel and beta-lapachone synergistically induce apoptosis in human retinoblastoma Y79 cells by downregulating the levels of phospho-Akt.

2009

Paclitaxel (PTX) and beta-lapachone (LPC) are naturally occurring compounds that have shown a large spectrum of anticancer activity. In this article we show for the first time that PTX/LPC combination induces potent synergistic apoptotic effects in human retinoblastoma Y79 cells. Combination of suboptimal doses of PTX (0.3 nM) and LPC (1.5 microM) caused biochemical and morphological signs of apoptosis at 48 h of treatment. These effects were accompanied by potent lowering in inhibitor of apoptosis proteins and by activation of Bid and caspases 3 and 6 with lamin B and PARP breakdown. PTX/LPC combination acted by favoring p53 stabilization through a lowering in p-Akt levels and in ps166-MDM…

Time FactorsPhysiologyClinical BiochemistryApoptosisInhibitor of Apoptosis ProteinsWortmanninchemistry.chemical_compoundSettore BIO/10 - BiochimicaAntineoplastic Combined Chemotherapy ProtocolsPhosphorylationCaspasebiologyCaspase 6Lamin Type BCaspase 3Protein StabilityRetinoblastomaDrug SynergismProto-Oncogene Proteins c-mdm2TransfectionBiochemistrylipids (amino acids peptides and proteins)Poly(ADP-ribose) PolymerasesWortmanninBH3 Interacting Domain Death Agonist Proteinretinoblastoma survival factors apoptosisPaclitaxelCell SurvivalPoly ADP ribose polymeraseActive Transport Cell NucleusDown-RegulationInhibitor of apoptosisTransfectionCell Line TumorHumansProtein kinase BProtein Kinase InhibitorsCell NucleusDose-Response Relationship DrugCell BiologyAntineoplastic Agents PhytogenicAndrostadieneschemistryCell cultureApoptosisbiology.proteinCancer researchTumor Suppressor Protein p53Proto-Oncogene Proteins c-aktNaphthoquinonesJournal of cellular physiology
researchProduct

Occupational health disparities among U.S. long-haul truck drivers: the influence of work organization and sleep on cardiovascular and metabolic dise…

2018

Objective The organization of work has undergone vast transformations over the past four decades in the United States and has had profound impacts on worker health and wellbeing. The profession of commercial truck driving is one of the best examples. Particularly for long-haul truck drivers, changes in work organization have led to disproportionately poor physiological, psychological, and sleep health outcomes. Methods The present study examined disparities in cardiometabolic disease risk among long-haul truck drivers and the general population, and the influence of work organization and sleep in generating these outcomes. Researchers collected survey data from 260 drivers, and blood assay …

Time FactorsPulmonologyDatabases FactualPhysiologyApneaCross-sectional studylcsh:MedicineBlood PressureCardiovascular MedicineLogistic regressionVascular MedicineBiochemistryOccupational safety and health0302 clinical medicineRisk FactorsMedicine and Health SciencesPublic and Occupational Health030212 general & internal medicinelcsh:ScienceMetabolic Syndromeeducation.field_of_studyMultidisciplinarySmokingMiddle AgedLipids030210 environmental & occupational healthCholesterolNeurologyCardiovascular DiseasesResearch ArticleAdultSleep ApneaNational Health and Nutrition Examination SurveyPopulation03 medical and health sciencesOccupational ExposureEnvironmental healthNorth CarolinamedicineHumanseducationbusiness.industryCholesterol HDLlcsh:RBiology and Life SciencesPhysical Activitymedicine.diseaseClinical trialCross-Sectional StudiesMetabolic DisordersSurvey data collectionlcsh:QMetabolic syndromePhysiological ProcessesSleepSleep DisordersbusinessAutomobileshuman activitiesPLoS ONE
researchProduct

Partially Reversible Adsorption of Annexin A1 on POPC/POPS Bilayers Investigated by QCM Measurements, SFM, and DMC Simulations

2005

The kinetics of annexin A1 binding to solid-supported lipid bilayers consisting of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC)/1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoserine (POPS; 4:1) has been investigated as a function of the calcium ion concentration in the bulk phase. Quartz crystal microbalance measurements in conjunction with scanning force microscopy, fluorescence microscopy, and computer simulations indicate that at a given Ca2+ concentration annexin A1 adsorbs irreversibly on membrane domains enriched in POPS. By contrast, annexin A1 adsorbs reversibly on the POPC-enriched phase, which is composed of single POPS molecules embedded within a POPC matrix. The overall are…

Time FactorsSurface PropertiesLipid BilayersKineticsAnalytical chemistryBiosensing TechniquesPhosphatidylserinesMicroscopy Atomic ForceBiochemistrychemistry.chemical_compoundAdsorptionPhase (matter)MicroscopyComputer SimulationParticle SizeLipid bilayerMolecular BiologyPOPCAnnexin A1ChemistryOrganic Chemistrytechnology industry and agricultureMembranes ArtificialQuartz crystal microbalanceMembraneMicroscopy FluorescencePhosphatidylcholinesMolecular Medicinelipids (amino acids peptides and proteins)AdsorptionStress MechanicalMonte Carlo MethodChemBioChem
researchProduct

Increased resistance to oxidation of betalain-enriched human low density lipoproteins

2003

Betalains are natural pigments recently considered as compounds with potential antioxidative properties. In this work, ex vivo plasma spiking of pure either betanin or indicaxanthin, followed by isolation of low density lipoprotein (LDL), and measurement of its resistance to copper-induced oxidation, has been used to research if these betalains can bind to LDL and prevent oxidation of LDL lipids. When pooled human plasma from 10 healthy volunteers was incubated in the presence of 25-100 microM either betanin or indicaxanthin, incorporation of both compounds in LDL was observed, with a maximum binding of 0.52 +/- 0.08, and 0.51 +/- 0.06 nmoles of indicaxanthin and betanin, respectively, per …

Time Factorsmedicine.medical_treatmentBetalainsIndicaxanthinBiochemistryBetaninPyruAntioxidantsPyrusNatural antioxidantchemistry.chemical_compoundLipid oxidationQuaternary Ammonium CompoundBetalainmedicineHumansBetaninHuman LDLTime Factors.Dose-Response Relationship DrugVitamin ECarotenePrickly pearGeneral MedicineHydrogen PeroxideQuaternary Ammonium CompoundsLipoproteins LDLOxygenDose–response relationshipchemistryBiochemistryModels ChemicalLow-density lipoproteinlipids (amino acids peptides and proteins)AntioxidantBetalainIndicaxanthinHumanProtein Binding
researchProduct

Prostaglandin E(2)-loaded microspheres as strategy to inhibit phagocytosis and modulate inflammatory mediators release.

2008

PGE(2), an arachidonic acid metabolite produced by various type of cells regulates a broad range of physiological activities in the endocrine, cardiovascular, gastrointestinal, and immune systems, and is involved in maintaining the local homeostasis. In the immune system, PGE(2) is mainly produced by APCs and it can suppress the Th1-mediated immune responses. The aim of this study was to develop PGE(2)-loaded biodegradable MS that prolong and sustain the in vivo release of this mediator. An o/w emulsion solvent extraction-evaporation method was chosen to prepare the MS. We determined their diameters, evaluated the in vitro release of PGE(2), using enzyme immunoassay and MS uptake by periton…

Time Factorsmedicine.medical_treatmentPhagocytosisChemistry PharmaceuticalDrug CompoundingPharmaceutical ScienceInflammationPharmacologyBiologyNitric OxideDinoprostonechemistry.chemical_compoundMiceImmune systemPhagocytosisIn vivoSepsismedicineAnimalsHumansImmunologic FactorsProstaglandin E2Particle SizeCells CulturedChemokine CCL2Tumor Necrosis Factor-alphaEndothelial CellsWaterGeneral MedicineMicrospheresDisease Models AnimalchemistryBiochemistrySolubilityDelayed-Action PreparationsMacrophages PeritonealLiberationlipids (amino acids peptides and proteins)Arachidonic acidEmulsionsmedicine.symptomInflammation MediatorsOilsBiotechnologyProstaglandin Emedicine.drugEuropean journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
researchProduct